-
InnoCare Announces First Patient Dosed in the Phase II/IIII Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Vitiligo in China
PharmaSources
May 16, 2025
InnoCare Pharma announced today that the first patient has been dosed in the Phase II/III clinical trial of its novel TYK2 inhibitor, Soficitinib (ICP-332), for the treatment patients with non-segmental vitiligo in China.
-
Brain Organoids & Mini-Brains: Revolutionizing Drug Discovery
Nurah Ekhlaque
May 15, 2025
Explore how brain organoids and mini-brains are transforming neurological drug discovery, disease modeling, and personalized medicine breakthroughs.
-
Data Loggers for pharma applications
Muhammad Asim Niazi
May 15, 2025
A Data Logger is an instrument to measure, monitor, and record data automatically. They can be integrated with any pharma process without limiting or degrading the performance of the pharma process.
-
Design Considerations for Steam Generator Specification
Muhammad Asim Niazi
May 15, 2025
A pure steam generator is equipment used to produce clean steam. The feed water is heated until it converts its phase from water to gaseous, i.e., steam, like the usual boiler.
-
Recent Job Cuts in FDA and other pharmaceutical companies, and the impact on the industry
Muhammad Asim Niazi
May 15, 2025
The pharma industry faces downsizing in various areas, where a number of employees are fired or relieved of their duties.In addition to the manufacturing industry, the FDA also faces job and funding cuts.
-
Digital Transformation in the Field of Pharma Supply Chain
Muhammad Asim Niazi
May 15, 2025
Digital transformation is becoming the new norm of the pharma industry that aids the industry in achieving its business targets.
-
Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China
ACN Newswire
May 07, 2025
Everest Medicines announced that the supplemental New Drug Application (sNDA) for NEFECON has received full approval from the China National Medical Products Administration (NMPA).
-
3D Printing in Pharmaceuticals: Transforming Drug Design, Production, and Delivery
Saher Haider
May 06, 2025
This article will explore 3D printing's current applications in pharmaceutical production, personalized medicine, and drug discovery, and the future potential of this groundbreaking technology.
-
Radioconjugates: Targeting for Precision
Suzanne Elvidge
May 06, 2025
The development of radioconjugates – targeted molecules designed to carry radionuclides directly to cancerous cells, lowering systemic exposure and increasing the precision of treatment.
-
Now and Next in Type 2 Diabetes
Suzanne Elvidge
May 06, 2025
Type 2 diabetes, the most common form of diabetes, affects more than 800 million adults worldwide.